Management of Hyperglycemia Due to Chemotherapy and Steroids

Introduction to Hyperglycemia Management

• The American College of Physicians recommends starting NPH insulin at 0.3-0.5 units/kg/day given in the morning to match the afternoon peak hyperglycemic effect of glucocorticoids, with dose adjustments proportional to steroid tapering 1, 2
• Peak hyperglycemia occurs 6-9 hours after morning steroid administration, typically in the afternoon and evening, with glucose levels often normalizing overnight even without treatment 1, 2

Understanding the Hyperglycemic Pattern

• The degree of hyperglycemia directly correlates with the steroid dose—higher doses cause more significant elevations 1, 3
• Prednisolone causes hyperglycemia predominantly between midday and midnight, with peak effects approximately 8 hours after morning administration 3

Immediate Monitoring Protocol

• Implement four-times-daily glucose monitoring (fasting and 2 hours after each meal) rather than relying on fasting glucose alone, which will miss the peak hyperglycemic effect 1, 2
• Target glucose range: 5-10 mmol/L (90-180 mg/dL) 1, 2, 3

Insulin Therapy Algorithm

• NPH insulin is the preferred agent because its 4-6 hour peak action aligns with the peak hyperglycemic effect of morning glucocorticoid doses 1, 2
• Starting dose: 0.3-0.5 units/kg/day given in the morning (or 3 hours after steroid administration) 1, 2, 3
• Higher doses (40-60% increase) may be needed for patients on high-dose glucocorticoids (e.g., prednisone ≥50 mg), those with higher baseline HbA1c, or pre-existing diabetes 1, 2

Dose Adjustment Strategy

• As steroids are tapered, insulin doses must be proportionally decreased to prevent hypoglycemia 1, 2, 3
• Adjust insulin based on blood glucose patterns, focusing on afternoon/evening readings 1, 2

Role of Oral Antidiabetic Agents

• Oral agents alone are insufficient for high-dose steroid therapy 2, 3
• Metformin can be added as an adjunct in patients with preserved renal and hepatic function, with some evidence it alleviates metabolic effects of steroids 2, 4

Critical Warning Signs

• Hyperosmolar hyperglycemic state can develop in very severe cases 1, 2, 3
• Warn patients that capillary blood glucose persistently above 20 mmol/L despite treatment, or glucose meter reading "HI," requires immediate hospital presentation 3, 4

Patient Education Requirements

• Provide comprehensive education on glucose monitoring technique and frequency (four times daily), symptoms of severe hyperglycemia and emergency thresholds, symptoms of hypoglycemia as insulin is initiated, and when to seek medical attention (persistent glucose >20 mmol/L) 1, 2, 3

Management of Steroid-Induced Hyperglycemia

Insulin Therapy

• For severe steroid-induced hyperglycemia, continuous intravenous insulin infusion is the preferred regimen, with a target glucose of 140-180 mg/dL, according to The Lancet Diabetes and Endocrinology 5
• The American Diabetes Association recommends adjusting insulin doses proportionally to steroid dose reductions to prevent hypoglycemia, with a decrease in insulin dose by the same percentage as the steroid dose reduction 6

Adjunctive Therapy

• Metformin can be added to insulin therapy in patients with preserved renal and hepatic function, as recommended by the Journal for ImmunoTherapy of Cancer, with some evidence that it alleviates metabolic effects of steroids 6

Patient Education

• Patients should be educated on symptoms of severe hyperglycemia and emergency thresholds, including capillary blood glucose persistently above 20 mmol/L (360 mg/dL) despite treatment, as warned by the Journal for ImmunoTherapy of Cancer 6
• The Journal for ImmunoTherapy of Cancer emphasizes the importance of reviewing insulin doses when adjustments to steroids are made, to prevent hypoglycemia or hyperglycemia 6